Observe Medical ASA (FRA:OM50) Moat Score: 0/10 (As of Jul. 12, 2026)


FRA:OM50 Observe Medical ASA FRA:OM50
32 GF Score
Price €0.09
GF Value €0.02
! 5 Warning Signs
View Full Analysis

What is Observe Medical ASA Moat Score?

Observe Medical ASA has the Moat Score of 0, which implies that the company might have No Moat - No discernible moat.

Observe Medical ASA has

Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more.

The company's Moat Score is based on these criteria:

1. Market leadership and sustainable market share
2. Network effects and significant customer switching costs
3. Valuable intellectual property and patents
4. Strong brand strength and deep customer loyalty
5. Durable cost advantages (e.g., economies of scale, proprietary technology)
6. Significant regulatory barriers and exclusive licenses
7. Superior distribution network
8. Strong and sustainable pricing power
9. Consistent and impactful innovation and R&D capabilities

Based on the research, GuruFocus believes Observe Medical ASA might have No Moat - No discernible moat.

Observe Medical ASA  (FRA:OM50) Moat Score Explanation

The Moat Score ranges from 0 to 10, with 10 as the highest. GuruFocus divided Moat Score into following 8 categories:

Moat Score Moat Level
10Wide Moat - Exceptionally dominant and durable wide moat
8 - 9Wide Moat - Clear and robust wide moat
7Wide Moat - Entry-level wide moat, clearly possessing durable advantages
6Narrow Moat - Strong narrow moat, clearly distinguishable but not wide
5Narrow Moat - Solid narrow moat
4Narrow Moat - Discernible but modest moat
1 - 3No Moat - Very weak/transient advantages
0No Moat - No discernible moat

Observe Medical ASA Moat Score Related Terms

FRA:OM50
32GF Score
Observe Medical ASA FRA:OM50
Moat Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Observe Medical ASA (FRA:OM50) Overvalued in 2026?

Based on GuruFocus' analysis, Observe Medical ASA stock appears to be overvalued. The current stock price of €0.09 is trading 347% above its estimated GF Value™ of €0.02.

Key valuation signals for FRA:OM50:

  • Moat Score: 0
  • GF Value™: €0.02 vs. price of €0.09 (347% above fair value)
  • GF Score™: 32/100 with 5 warning signs

No single metric tells the full story. See the FRA:OM50 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Observe Medical ASA Business Description

Other Exchanges OBSRV:Norway
Address Dronning Eufemias gate 16, Oslo, NOR, 0191
Observe Medical ASA is a Nordic medtech company focused on the development, commercialization, and scaling of medical technologies for the healthcare markets. The company's portfolio of proprietary products consists of: Sippi, a CE marked digitalized system for urine output measurement, the UnoMeter portfolio consisting of manual urine output measurement products and solutions for measuring intra-abdominal pressure. The company operates internationally through subsidiaries in Norway, Sweden and Denmark.
32GF Score

Get the complete analysis for FRA:OM50

Moat Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.09
Price
€0.02
GF Value